NCT02916316 Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell Status COMPLETED Phase N/A
NCT02909777 Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma Status COMPLETED Phase PHASE1
NCT02905942 PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation Status UNKNOWN Phase PHASE4
NCT02905916 The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy Status UNKNOWN Phase PHASE4
NCT02898259 Lenalidomide, Ixazomib, and Rituximab as Front-Line Therapy for High Risk Indolent B-Cell Lymphoma Status TERMINATED Phase PHASE1/PHASE2
NCT02889523 Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02885038 Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies Status COMPLETED Phase N/A
NCT02875002 Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas Status WITHDRAWN Phase PHASE1
NCT02858167 Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations Status COMPLETED Phase NA
NCT02857426 A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) Status COMPLETED Phase PHASE2
NCT02856048 Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT02836834 Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT02821793 Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer Status COMPLETED Phase N/A
NCT02805218 PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy Status COMPLETED Phase PHASE4
NCT02800889 Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer Status WITHDRAWN Phase PHASE1